Position cooling packs carefully to avoid direct contact with the medication, preventing freezing
Maintaining open communication with your healthcare provider ensures both mental health benefits and physical well-being are preserved.
March 3, 2025: Go-Forward Plan in Ozempic Lawsuits Discussed During Status Hearing In a recent status conference for the Ozempic group lawsuit, Judge Karen Spencer Marston discussed a number of important milestones for GLP-1 lawsuits in 2025
Novo Nordisk is actively monitoring and taking action (including but not limited to issuing cease-and-desist letters) against those entities that are engaging in the unlawful sale of compounded semaglutide, disseminating false advertising, and infringing its trademarks. Scott Brunner, CEO of the Alliance for Pharmacy Compounding (A4PC), says that, based on reports from some compounding pharmacies, compounding pharmacies have been able to access semaglutide from legitimate FDA-registered facilities
Rybelsus is a medication with specific, approved medical uses
Webster, C